Napredna pretraga

Pregled bibliografske jedinice broj: 680621

Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases


Markeljević, Jasenka; Batinić, Drago; Užarević, Branka; Božikov, Jadranka; Čikes, Nada; Babić- Naglić, Đurđica; Horvat, Zvonimir; Marušić, Matko.
Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases // Journal of rheumatology. Supplement, 21 (1994), 12; 2225-2230 (međunarodna recenzija, članak, znanstveni)


Naslov
Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases

Autori
Markeljević, Jasenka ; Batinić, Drago ; Užarević, Branka ; Božikov, Jadranka ; Čikes, Nada ; Babić- Naglić, Đurđica ; Horvat, Zvonimir ; Marušić, Matko.

Izvornik
Journal of rheumatology. Supplement (0380-0903) 21 (1994), 12; 2225-2230

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Peripheral blood B cells; systemic connective tissue diseases
(Peripheral blood B cells; connective tissue diseases)

Sažetak
OBJECTIVE: To get a better insight into the level of circulating CD5+ B cells as related to the systemic connective tissue disease activity. METHODS: Peripheral blood CD5+CD19+ cells of patients in the remission phase of systemic lupus erythematosus (SLE) (n = 28), Sjögren's syndrome (SS) (n = 20), rheumatoid arthritis (RA) (n = 26), and 19 control healthy subjects were analyzed by 2-color flow cytometry. RESULTS: In comparison to control group, the patients with SLE had a significant increase in the relative CD19+CD5+ blood cell count (p < 0.0005) ; this count was also different from the finding in both RA (p < 0.005) and patients with SS (p < 0.05). In contrast, the proportion of B cells expressing CD5 (within an individual B cell population) was significantly increased in all the 3 diseases compared to healthy subjects (SLE, p < 0.0001 ; SS, p < 0.05 ; and RA, p < 0.01). In the multivariate discriminant analysis, a discriminant function defined by the CD19+CD5+ subset strongly discriminated SLE, SS and RA from the control, but also SLE from both SS and RA. CONCLUSION: objective: Our findings demonstrated that, in relation to healthy control subjects, the blood CD5+ B subset tended to be elevated in the patients in the remission phase of systemic connective tissue diseases, particularly in SLE.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

Časopis indeksira:


  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka:


  • PMID: 7535356 [PubMed - indexed for MEDLINE]